Comparison between Dev Labtech Venture IPO and Infinium Pharmachem IPO.
IPO Details
Dev Labtech Venture IPO is a SME Fixed Price IPO proposed to list at BSE SME while Infinium Pharmachem IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Dev Labtech Venture IPO is up to ₹10.65 Cr whereas the issue size of the Infinium Pharmachem IPO is up to ₹23.99 Cr. The final issue price of Dev Labtech Venture IPO is ₹51.00 per share and of Infinium Pharmachem IPO is ₹135.00 per share.
IPO Timetable
Dev Labtech Venture IPO opens on Mar 17, 2023, while Infinium Pharmachem IPO opens on Mar 31, 2023. The closing date of Dev Labtech Venture IPO and Infinium Pharmachem IPO is Mar 21, 2023, and Apr 05, 2023, respectively.
| | Dev Labtech Venture IPO | Infinium Pharmachem IPO |
|---|
| Issue Open | Mar 17, 2023 | Mar 31, 2023 |
| Issue Close | Mar 21, 2023 | Apr 05, 2023 |
| Basis Of Allotment (Tentative) | Mar 24, 2023 | Apr 11, 2023 |
| Initiation of Refunds (Tentative) | Mar 27, 2023 | Apr 12, 2023 |
| Credit of Share (Tentative) | Mar 28, 2023 | Apr 13, 2023 |
| Listing date (Tentative) | Mar 29, 2023 | Apr 17, 2023 |
Financials & KPIs
Dev Labtech Venture IPO P/E ratio is 32.9, as compared to Infinium Pharmachem IPO P/E ratio of 7.83.
Shares Offered
In the Dev Labtech Venture IPO Retail Individual Investors (RII) are offered 10,44,000 shares while in Infinium Pharmachem IPO retail investors are offered 10,44,000 shares. Qualified Institutional Buyers (QIB) are offered in Dev Labtech Venture IPO and in Infinium Pharmachem IPO.
| | Dev Labtech Venture IPO | Infinium Pharmachem IPO |
|---|
| Market Maker Reservation | 1,12,000 shares | 94,000 shares |
| NII | 10,44,000 shares | 8,70,000 shares |
| RII | 10,44,000 shares | 8,70,000 shares |
| Employee | | 41,000 shares |
| Total | 20,88,000 shares | 17,81,000 shares |
Bids Received (Subscription)
Dev Labtech Venture IPO subscribed 5.45x in total, whereas Infinium Pharmachem IPO subscribed 1.92x.
